Over the past decade or more, phrases like “value-based care” and “patient centricity” have evolved to a position of greater ...

In addition to working with some of the most innovative companies in the life sciences industry, one of the greatest ...

The FDA's Plan to Transform & Evolve Through Data

Life sciences companies will need to reevaluate their marketing approach as off-label and direct-to-customer (DTC) marketing continue to draw attention. In recent ...

As pharmaceutical companies introduce new therapies to the U.S. market, they respond to risk-sharing agreements (RSAs) from healthcare providers, which ...

The 2.3 percent excise tax on medical devices has been one of the more publicly controversial inclusions in the five-year-old ...

The Department of Homeland Security is currently investigating dozens of cybersecurity cases related to medical devices and their potential for ...

Recent advances in technology have introduced consumers to a range of devices that have the potential to improve and extend ...

The value-based healthcare model is pushing life science companies towards precision medicine, which requires extensive data analysis, technology integration and ...

To explore our 2015 Life Sciences Trends Report, download the PDF here or view an abbreviated overview below. In 2015, ...

One of our experts was recently a panelist at the MMA Roadshow workshop on “Managing App Development under FDA Regulation,” ...

In 2013, US Customs & Border Protection seized more than 2,350 parcels containing counterfeit medical devices and pharmaceutical products valued ...